Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

62.98
Delayed Data
As of Nov 27
 +5.97 / +10.47%
Today’s Change
19.51
Today|||52-Week Range
73.72
-0.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Anzalone Christopher Richard
Chief Executive Officer
Sale12/24/201983,333$63.50$5.3M-2.43%
Anzalone Christopher Richard
Chief Executive Officer
Sale10/23/202087,728$58.16$5.1M+6.98%
Anzalone Christopher Richard
Chief Executive Officer
Sale12/12/201958,059$67.31$3.9M-6.43%
Anzalone Christopher Richard
Chief Executive Officer
Sale6/25/202099,977$38.81$3.9M+49.16%
Anzalone Christopher Richard
Chief Executive Officer
Sale12/13/201945,577$66.47$3.0M-5.22%
Anzalone Christopher Richard
Chief Executive Officer
Sale8/13/202050,000$41.35$2.1M+47.48%
Myszkowski Kenneth Allen
Chief Financial Officer
Sale11/09/202025,840$69.04$1.8M-7.50%
Anzalone Christopher Richard
Chief Executive Officer
Sale12/13/201925,412$67.30$1.7M-5.22%
Myszkowski Kenneth Allen
Chief Financial Officer
Sale10/20/202029,166$54.04$1.6M+15.07%
Anzalone Christopher Richard
Chief Executive Officer
Sale12/12/201923,219$66.82$1.6M-6.43%
Page of 11